What is DirectMeds?
DirectMeds is a telehealth platform focused on medically supervised weight loss, offering physician-prescribed access to compounded GLP-1 medications — specifically semaglutide and tirzepatide — at dramatically lower prices than brand-name alternatives.
The platform sits in a crowded space, but distinguishes itself through genuine pricing transparency, a straightforward clinical process, and strong nationwide availability. It's the platform we recommend most often to people who simply want effective, affordable, clinician-supervised GLP-1 access without navigating a complicated system.
How DirectMeds works
- Free eligibility checkComplete a short online health intake covering your height, weight, medical history, and weight loss goals. Takes under 10 minutes. No cost to find out if you qualify.
- Physician reviewA licensed clinician reviews your intake and determines whether GLP-1 therapy is appropriate for you. This is a real clinical review — not an automated system rubber-stamping applications.
- Personalized prescriptionIf approved, your physician prescribes a starting dose of compounded semaglutide or tirzepatide with a titration schedule designed to minimize side effects while building toward an effective therapeutic dose.
- Pharmacy dispensing and deliveryYour prescription is filled by an licensed compounding pharmacy and shipped directly to you. Most patients receive their first order within 5–7 business days of approval.
- Ongoing monitoringRegular check-ins with your provider to track progress, manage any side effects, and adjust dosing as needed. This ongoing clinical relationship is what separates DirectMeds from simple online pharmacies.
Pricing — what DirectMeds actually costs
This is where DirectMeds earns its top rating. Pricing is straightforward and disclosed clearly before you commit:
- Compounded semaglutide: Starting around $99–$149/month at introductory doses, typically rising to $149–$249/month at higher maintenance doses
- Compounded tirzepatide: Generally $149–$299/month depending on dose
- Physician consultation: Included in the monthly program cost — no separate consultation fee
- Ongoing monitoring: Included
Compare this to higher-cost brand-name alternatives and it becomes clear why compounded GLP-1 telehealth has become the dominant access route for most patients in 2026. DirectMeds sits at the more affordable end of the compounded telehealth market without compromising on clinical quality.
DirectMeds does not accept insurance. HSA/FSA funds may apply depending on your plan.
Clinical quality — how does the medical oversight actually hold up?
Our most important evaluation criterion is always clinical quality — because a platform that makes GLP-1 medications easy to get without appropriate medical oversight is dangerous, not helpful.
DirectMeds passes this test. Every prescription decision involves a licensed physician review of your health history and current medications. The titration schedules prescribed are consistent with clinical best practices — starting low and increasing gradually to minimize gastrointestinal side effects. And the ongoing monitoring relationship gives patients a clinical contact point if issues arise.
What we look for and what DirectMeds delivers: real physician involvement at every prescription decision, screening for contraindications (history of thyroid cancer, pancreatitis, pregnancy), appropriate starting doses, and ongoing access to clinical support. All of those boxes are checked.
How DirectMeds compares to other GLP-1 platforms
| Feature | DirectMeds | Zealthy | Trimi | AM Rx |
|---|---|---|---|---|
| Compounded semaglutide | ✓ Yes | ✓ Yes | ✓ Yes | ✓ Yes |
| Compounded tirzepatide | ✓ Yes | ✓ Yes | ✓ Yes | Limited |
| Starting price | ~$99/mo | ~$149/mo | ~$99/mo | ~$129/mo |
| Physician consultation included | ✓ Yes | ✓ Yes | ✓ Yes | ✓ Yes |
| All 50 states | ✓ Yes | ✓ Yes | Most states | ✓ Yes |
| Ongoing monitoring | ✓ Yes | ✓ Yes | ✓ Yes | Limited |
Who DirectMeds is right for
DirectMeds is an excellent fit for most adults seriously considering GLP-1 therapy:
- Adults with BMI 30+ looking for the most affordable legitimate GLP-1 access
- Adults with BMI 27–29.9 with a qualifying condition (diabetes, hypertension, high cholesterol, sleep apnea)
- People who have looked at compounded alternatives pricing and need a realistic alternative
- Anyone who wants a fully online process without in-person clinic visits
- Patients who want ongoing clinical monitoring rather than a one-time prescription
DirectMeds is a less ideal fit if you need specialized hormonal support (see FemExcel for women or Rugiet for men), or if you're specifically interested in longevity interventions beyond weight loss (see AgelessRx).
Side effects — what to expect
GLP-1 medications have a well-documented side effect profile. The most common are gastrointestinal: nausea, vomiting, diarrhea, and constipation — particularly in the early weeks as your dose is being established. These typically improve as your body adjusts and as your dose is titrated gradually.
Less common but more serious side effects include pancreatitis, gallbladder disease, and (very rarely) thyroid tumors. These are screened for during intake. Your DirectMeds physician will discuss the full risk-benefit profile with you before prescribing.
The gradual titration schedule that DirectMeds uses — starting at a low dose and increasing over several months — is specifically designed to minimize GI side effects and is consistent with how obesity medicine specialists approach GLP-1 prescribing.
Check your eligibility at DirectMeds
The eligibility check is free and takes under 10 minutes. A licensed physician reviews every application — no automated approvals. Compounded semaglutide starts at approximately $99/month.
Check your DirectMeds eligibility →Frequently asked questions
Our verdict
DirectMeds earns its position as our top-rated GLP-1 telehealth platform for 2026. The combination of genuine pricing transparency, real physician oversight, strong nationwide availability, and access to both semaglutide and tirzepatide makes it the default recommendation for most people researching compounded GLP-1 therapy.
It's not the only good option — see our full 2026 rankings for a complete comparison — but for straightforward GLP-1 access with solid clinical standards, DirectMeds is where we'd start.
Rating: 4.8/5 · Editor's Pick for 2026
Check your DirectMeds eligibility → Free eligibility check · Physician review required · Prescription medications carry risks